Figure S1. CircRNA candidates identified from 5 polyribosome profiling studies. Figure S2. Analysis of common targets for circSDHAF2. Figure S3. circSDHAF2 associated with actively translating ribosomes. Figure S4. CircSDHAF2 produces proteins. Figure S5. Intron 2 does not promote nuclear export. Figure S6. Spliceosome inhibitor suppressed circCoding reporter activity. Figure S7. Elevated splicing-mediated cap-independent translation activity in CRC cells. Figure S8. Knockdown of circSDHAF2 suppresses development of tumorspheres. Figure S9. Demographic information of CRC patients.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: